New York Gov. Kathy Hochul announced she would not remove New York City Mayor Eric Adams from office over federal corruption ...

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the popular diabetes and obesity treatments continue to improve, federal regulators ...

JPMorgan is sticking with Eli Lilly (LLY) as its top biopharma pick for 2025, while also highlighting Gilead Sciences (GILD) ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... risk assessment, and the power of compounding—principles that can shape their financial future.

(WCTV/Gray Florida Capital Bureau ... Her 13-year-old daughter Lilly Glaubach was killed in 2022 while riding her bike home from school in Sarasota County. The driver never stopped until ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast.

Eli Lilly and Co. shares climbed about 2% Thursday morning to $857.40 while broader trading indexes started the day mixed. Lilly's stock has already climbed 9% so far this year, as of Wednesday. Share ...